Biotechnology - Monoclonal Antibodies

Exercise : Monoclonal Antibodies - Section 1
  • Monoclonal Antibodies - Section 1
1.
The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as
transformation of antigen specific B lymphocytes (EBV)
hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes
combination of EB Vand hybridoma techniques
all of these
Answer: Option
Explanation:
No answer description is available. Let's discuss.

2.
Some cross reactions with monoclonal antibodies (MAbs) can occur. Unexpected cross reactions occur more frequently with
Ig MAbs
IgG
IgA
IgE
Answer: Option
Explanation:
No answer description is available. Let's discuss.

3.
Preliminary clinical results with a humanized antibody against the interleukin-2 receptor have suggested the
absence of human immune response against murine proteins (HAMA) response
presence of HAMA response
poor recognition of immunoglobulin, Ig constant regions
all of the above
Answer: Option
Explanation:
No answer description is available. Let's discuss.

4.
The cross linkage of antigens by antibodies is known as
agglutination
complement fixation
a cross reaction
all of these
Answer: Option
Explanation:
No answer description is available. Let's discuss.

5.
In monoclonal antibody technology, tumor cells that can replicate endlessly are fused with mammalian cells that produce an antibody. The result of this cell fusion is a
hybridoma
myeloma
natural killer cell
lymphoblast
Answer: Option
Explanation:
No answer description is available. Let's discuss.